NCRI 2018 | Immunotherapeutic landscape for head and neck cancer
Speaking from the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Quynh-Thu Le, MD, from Stanford University, Stanford, CA, discusses the current immunotherapeutic landscape for head and neck cancer. Prof. Le discusses the progress made in the recurrent setting, and highlights investigations now moving into the frontline. She also explains the toxicities to be aware of when using immunotherapy in this malignancy.
Get great new content delivered to your inboxSign up